SCHEMBL30518100

SCHEMBL30518100

N=C(N)NCCC[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)CNC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CCCCN)C(=O)O

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ C5AR1 P21730 2/20 0.63
▸ NPBWR1 P48145 3/20 0.57
▸ IL23R Q5VWK5 12/20 0.53
▸ TUBB4A P04350 1/20 0.53
▸ TUBB P07437 1/20 0.53
▸ TUBA3C P0DPH7 1/20 0.53
▸ TUBA1B P68363 1/20 0.53
▸ TUBA4A P68366 1/20 0.53
▸ TUBB4B P68371 1/20 0.53
▸ TUBB3 Q13509 1/20 0.53
▸ TUBB2A Q13885 1/20 0.53
▸ TUBB8 Q3ZCM7 1/20 0.53
▸ TUBA3E Q6PEY2 1/20 0.53
▸ TUBA1A Q71U36 1/20 0.53
▸ TUBA1C Q9BQE3 1/20 0.53
▸ TUBB6 Q9BUF5 1/20 0.53
▸ TUBB2B Q9BVA1 1/20 0.53
▸ TUBB1 Q9H4B7 1/20 0.53
▸ GLP1R P43220 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31680253 0.94 C5AR1 (0.61) C5AR1NPBWR1TUBB4ATUBBTUBA3C
SCHEMBL29484172 0.93 C5AR1 (0.59) C5AR1NPBWR1IL23RTUBB4ATUBB
SCHEMBL29461969 0.93 C5AR1 (0.61) C5AR1NPBWR1IL23RGLP1R
SCHEMBL30518134 0.93 C5AR1 (0.59) C5AR1NPBWR1IL23RTUBB4ATUBB
SCHEMBL29461975 0.93 C5AR1 (0.62) C5AR1NPBWR1IL23R
SCHEMBL29419495 0.92 C5AR1 (0.59) C5AR1NPBWR1IL23RTUBB4ATUBB
SCHEMBL30518095 0.92 NPBWR1 (0.64) C5AR1NPBWR1IL23R
SCHEMBL30518165 0.92 NPBWR1 (0.64) C5AR1NPBWR1IL23R
SCHEMBL30518049 0.92 C5AR1 (0.53) C5AR1NPBWR1GLP1R
SCHEMBL31680254 0.91 C5AR1 (0.58) C5AR1NPBWR1IL23RTUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260078144-A1 ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF WINKEY TECH USA INC (US) 2026-03-19 — — US claimed
WO-2024217503-A1 ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF 深圳市维琪科技股份有限公司 2024-10-24 — — WO claimed
CN-116535463-A Active peptide, composition and use thereof 深圳市维琪科技股份有限公司 2023-08-04 — — CN claimed
US-20260078144-A1 ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF WINKEY TECH USA INC (US) 2026-03-19 — — US disclosed
WO-2024217503-A1 ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF 深圳市维琪科技股份有限公司 2024-10-24 — — WO disclosed
CN-117343140-B Active peptide, composition and use thereof 深圳市维琪科技股份有限公司 2024-09-20 — — CN disclosed
CN-117343140-A Active peptide, composition and use thereof 深圳市维琪科技股份有限公司 2024-01-05 — — CN disclosed
CN-116535463-B Active peptide, composition and use thereof 深圳市维琪科技股份有限公司 2023-10-31 — — CN disclosed
CN-116535463-A Active peptide, composition and use thereof 深圳市维琪科技股份有限公司 2023-08-04 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260078144-A1 ACTIVE PEPTIDE, AND COMPOSITION AND USE THEREOF ARGLU1, ARG1, POT1 C5AR1 1713/4885NPBWR1 71/4885IL23R 4196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback